1. Home
  2. KRYS vs TREX Comparison

KRYS vs TREX Comparison

Compare KRYS & TREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • TREX
  • Stock Information
  • Founded
  • KRYS 2015
  • TREX 1996
  • Country
  • KRYS United States
  • TREX United States
  • Employees
  • KRYS N/A
  • TREX N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • TREX
  • Sector
  • KRYS Health Care
  • TREX
  • Exchange
  • KRYS Nasdaq
  • TREX Nasdaq
  • Market Cap
  • KRYS 6.3B
  • TREX 5.5B
  • IPO Year
  • KRYS 2017
  • TREX 1999
  • Fundamental
  • Price
  • KRYS $221.08
  • TREX $35.31
  • Analyst Decision
  • KRYS Strong Buy
  • TREX Buy
  • Analyst Count
  • KRYS 9
  • TREX 18
  • Target Price
  • KRYS $214.22
  • TREX $55.59
  • AVG Volume (30 Days)
  • KRYS 335.7K
  • TREX 4.5M
  • Earning Date
  • KRYS 11-03-2025
  • TREX 11-04-2025
  • Dividend Yield
  • KRYS N/A
  • TREX N/A
  • EPS Growth
  • KRYS 275.72
  • TREX N/A
  • EPS
  • KRYS 6.66
  • TREX 1.84
  • Revenue
  • KRYS $373,164,000.00
  • TREX $1,180,769,000.00
  • Revenue This Year
  • KRYS $34.33
  • TREX $8.82
  • Revenue Next Year
  • KRYS $48.04
  • TREX $7.34
  • P/E Ratio
  • KRYS $32.83
  • TREX $18.94
  • Revenue Growth
  • KRYS 54.51
  • TREX 0.10
  • 52 Week Low
  • KRYS $122.80
  • TREX $29.77
  • 52 Week High
  • KRYS $221.84
  • TREX $80.74
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 76.21
  • TREX 41.28
  • Support Level
  • KRYS $203.17
  • TREX $29.77
  • Resistance Level
  • KRYS $212.97
  • TREX $33.00
  • Average True Range (ATR)
  • KRYS 7.05
  • TREX 1.46
  • MACD
  • KRYS 0.96
  • TREX 0.75
  • Stochastic Oscillator
  • KRYS 98.60
  • TREX 97.39

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

Share on Social Networks: